Trending News Today: Gilead HCV Drug Patents Challenged
Gilead’s Lucrative Hep C Patents Face PTAB Assault
Gilead faces challenge to U.S. hepatitis C patents from advocacy group
Consumer group challenges Gilead patents on hepatitis C drug
Gilead’s Patents on Hepatitis C Drug Challenged by Consumer Group
Health Group Challenges Gilead Patents In The US On Grounds Of Lack Of Novelty
First-Ever U.S. Patent Challenges Dispute Gilead’s Monopoly on Hepatitis C Drugs that Blocks Millions from Treatment
AbbVie’s New Hepatitis C Treatment Won’t Cure Patient Access Issue
WHO moves to widen access to generic Sovaldi in dozens of countries
After India, I-MAK files legal challenge against Gilead’s hepatitis C drug sofosbuvir in China